Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lymphoma
lymphoma
Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable
Forbes
Mon, 05/28/18 - 01:33 pm
CAR-T
CRS
lymphoma
leukemia
cytokine release syndrome
Hemo-oncology newbie Bayer gears up for copanlisib launch
Fierce Pharma
Wed, 09/13/17 - 10:37 am
hemo-oncology
Bayer
drug launches
copanlisib
lymphoma
Two cancer drug prices have already been hiked by 8% this year
Marketwatch
Wed, 07/5/17 - 09:35 am
drug pricing
cancer
Amgen
Blincyto
Teva Pharmaceutical
Treanda
lymphoma
leukemia
Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep
Endpoints
Tue, 06/20/17 - 09:20 am
Novartis
Gamida Cell
clinical trials
cell grafts
bone marrow
leukemia
lymphoma
Novartis' CAR-T stacks up to Kite in lymphoma
BioPharma Dive
Wed, 06/7/17 - 07:04 pm
Novartis
CAR-T
Kite Pharma
CTL019
axi-cel
lymphoma
Celldex Cancer Drug Shows Good Early Data
Investopedia
Wed, 11/16/16 - 09:49 am
Celldex Therapeutics
CDX-1140
lymphoma
Seattle Genetics moves up FDA timeline for cash cow drug Adcetris
Bizjournals.com
Sat, 11/12/16 - 09:13 am
Seattle Genetics
FDA
Adcetris
lymphoma
Glimpse of promising lymphoma responses spurs a sharp spike in Epizyme shares
Fierce Biotech
Tue, 06/23/15 - 10:23 am
lymphoma
EPZ-6438
Epizyme
JNJ launches PhII lymphoma study for daratumumab
Fierce Biotech
Thu, 12/4/14 - 04:13 pm
JNJ
lymphoma
daratumumab
Genmab
non-Hodgkin's lymphoma
US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL
PharmaBiz
Sat, 11/8/14 - 11:39 am
diffuse large B-cell lymphoma
lymphoma
MorphoSys
MOR208
Data on Celgene's Revlimid Published in Oncology Journal
Yahoo/Zacks
Sat, 08/23/14 - 09:52 am
Celgene
Revlimid
diffuse large B-cell lymphoma
lymphoma
ProNAi nabs $59.5M round to back PhII lymphoma drug
Fierce Biotech
Tue, 04/22/14 - 10:02 am
ProNai
PNT2258
lymphoma
Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers
Yahoo/BusinessWire
Sat, 12/7/13 - 12:47 pm
large B-cell lymphoma
lymphoma
leukemia
T-cell acute lymphoblastic leukemia
IPI-145
Infinity Pharmaceuticals
Seattle Genetics highlights ADCETRIS data at lymphoma conference
Yahoo/Fly on the Wall
Fri, 06/21/13 - 09:14 am
Seattle Genetics
Adcetris
lymphoma
Celgene's Revlimid wins additional FDA lymphoma approval
Reuters
Wed, 06/5/13 - 05:35 pm
Celgene
Revlimid
FDA
lymphoma
mantle cell lymphoma
Eli Lilly's lymphoma drug fails in late-stage trial
Reuters
Fri, 05/10/13 - 08:56 am
lymphoma
enzastaurin
Eli Lilly
Isis Pharma, AstraZeneca Ink Deal
Yahoo/Zacks
Sat, 12/15/12 - 12:50 pm
Isis Pharmaceuticals
AstraZeneca
ISIS-STAT3Rx
lymphoma
Pharmacyclics slumps on disappointing study data
Yahoo/AP
Mon, 11/5/12 - 12:45 pm
Pharmacyclics
ibrutinib
JNJ
lymphoma
leukemia
Spectrum Pharma Not Ready to Call Lymphoma Study a Win
TheStreet.com
Mon, 09/24/12 - 10:30 am
Spectrum Pharmaceuticals
lymphoma
belinostat
TopoTarget
peripheral T-cell lymphoma
Spectrum announces clinical data for ZEVALIN and Belinostat
The Fly on the Wall
Tue, 06/5/12 - 12:23 pm
Zevalin
labeling
Spectrum Pharmaceuticals
lymphoma
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »